Health ❯Healthcare

Obesity

Treatment Options Weight Loss Weight Management Weight Loss Treatments Health Risks Obesity Management Treatment Methods Obesity Treatment Childhood Obesity Obesity Treatments

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

The analysis underscores the importance of extended anti-obesity treatment with integrated lifestyle support to prevent rebound weight gain.

Intermittent Energy Restriction Shows Greatest Benefits in Diabetes Weight-Loss Trial

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

NHS Empowers GPs to Prescribe Mounjaro for Severe Obesity

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Novo Nordisk’s Amycretin Delivers Up to 24% Early Weight Loss in Dual-Form Trials

France to Let All Doctors Prescribe Wegovy and Mounjaro Starting June 23

NHS Expands Mounjaro Rollout as Regulators Flag Safety Concerns

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

High BMI and Black Patients Face Greater Minor Complication Risks After Bariatric Surgery

Italy Boosts Prevention Funding to Safeguard Health System

NHS to Expand GP Prescriptions of Mounjaro for Weight Loss

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections

Waist-to-Height Ratio Found to Strongly Predict Heart Failure Risk